Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play - Test2 - elhamkhani - TriplyDB

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play

http://www.wikidata.org/entity/Q27468870

about

Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies.Circulating and intrahepatic antiviral B cells are defective in hepatitis B

P2860

Q28068018-C3D00AA4-0D8C-4DDF-B265-530FF61E72D1 Q42225453-0A6E14C3-B2FF-4A4F-9FA5-D1144C7030AD Q47110966-41763F23-656D-4CE6-9AAF-D373CABF285E Q55407980-BDD4DC34-2159-4320-9CFF-11862556F523 Q58792007-55B37747-BE2D-453F-B8DC-99AE5A4EEF89

P2860

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play

http://www.wikidata.org/entity/Q27468870

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Converting monoclonal antibody ...... ing immune complexes into play

@ast

Converting monoclonal antibody ...... ing immune complexes into play

@en

Converting monoclonal antibody ...... ing immune complexes into play

@nl

type

label

Converting monoclonal antibody ...... ing immune complexes into play

@ast

Converting monoclonal antibody ...... ing immune complexes into play

@en

Converting monoclonal antibody ...... ing immune complexes into play

@nl

prefLabel

Converting monoclonal antibody ...... ing immune complexes into play

@ast

Converting monoclonal antibody ...... ing immune complexes into play

@en

Converting monoclonal antibody ...... ing immune complexes into play

@nl

P1433

Q27468870-34EBD7AE-E99E-4CED-871A-9F7D70395410

P1476

Q27468870-4B97AD17-EF73-47C5-92DF-638D8087291E

P2093

Q27468870-2747AECA-909F-4E15-9D71-9BBE50595197

Q27468870-712C7518-E231-4D29-98FF-4C4EAE8ADF77

Q27468870-94EDD489-FA3A-4B59-8E65-8369D6E736A1

P275

Q27468870-40EBD0C4-2C09-4740-8814-CC41FFC89B54

P2860

Q27468870-0565E41D-829F-4EA0-86C9-888DC9A3C4B9

Q27468870-098AC2FA-CCBE-4C50-8A8D-5B714E4B071E

Q27468870-0A77F5CD-0F2C-4E8A-BE43-610F258F44F6

Q27468870-0BD3B524-88F8-4A91-8107-FF6093E8D563

Q27468870-0CF3F779-3445-4D95-88A1-9DE696C57654

Q27468870-0D94C4BA-6AEC-4F31-BF2D-D09657A136D2

Q27468870-11964F9C-1391-4DD1-9F95-2DAB7648AA35

Q27468870-12096D0C-A93C-4A92-A711-CFCB630A3354

Q27468870-12F4AA5D-7E06-4975-9844-444A149C6A72

Q27468870-154E2959-FA83-4DA7-B609-F5EB3137A8C4

P2888

Q27468870-5ADFD9FD-5814-4484-B7DF-AB8AB2E5564B

P304

Q27468870-9A861323-DA61-4825-AA5E-78A30E93111F

P31

Q27468870-71229476-6DA9-4377-9514-7C0566181070

Q27468870-B89D27A1-A18E-4DD1-8977-676152F9C733

P3181

Q27468870-43A4A0DC-31F1-4DCC-B1BA-A287E5D9F48A

P356

Q27468870-1A61F18F-70A5-42D4-B5CE-58D1206B20A3

P433

Q27468870-3ABD0E04-421D-4455-BBFC-3E579CFA0751

P478

Q27468870-BA56219E-BA57-4F72-908F-AC0A1B44DAC0

P50

Q27468870-A1A9A0C0-E19F-4117-9339-15941100634A

P5008

Q27468870-0C0F4B19-41D5-4598-A2BD-79872CE6517D

P577

Q27468870-9D1A9562-1FD5-46A2-80D5-A982EFB8D0C5

P6179

Q27468870-AEC8F7A2-E2A5-41BE-821F-50F6A81F60DE

P698

Q27468870-24DACFFD-F70E-41D9-B8AF-B6A985A3E8FE

P921

Q27468870-28025235-52AA-4420-80A8-FF3A76683885

Q27468870-4F47F48F-9078-454C-AE3E-461CB7A36310

Q27468870-526F984B-8E83-4CD0-B3C8-B667D3438283

Q27468870-72E5CDF6-B29B-4812-90CF-ED1F0AAB9506

Q27468870-78A7DB28-A194-431C-8A3B-310792887520

Q27468870-A7B0219D-5915-49A0-9418-360EDD77941B

Q27468870-CFBBAEA7-98FE-4395-BCFD-9E54DD013E24

P932

Q27468870-D227464C-2160-4B1F-98EE-C4AE176354D9

P3181

P356

P1433

Emerging microbes & infections

P1476

Converting monoclonal antibody ...... ing immune complexes into play

@en

P2093

Jennifer Lambour

http://www.w3.org/2001/XMLSchema#string

Mar Naranjo-Gomez

http://www.w3.org/2001/XMLSchema#string

Marc Piechaczyk

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases

A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy

Impaired antibody response causes persistence of prototypic T cell-contained virus

An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV

Fcgamma receptors as regulators of immune responses

Cutting edge: Ly49C/I⁻ neonatal NK cells predispose newborns to autoimmune ovarian disease induced by maternal autoantibody.

The unique neonatal NK cells: a critical component required for neonatal autoimmune disease induction by maternal autoantibody

A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

P2888

P304

e92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2691793

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/EMI.2016.97

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Mireia Pelegrin

P5008

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008865669

http://www.w3.org/2001/XMLSchema#string

P698

27530750

http://www.w3.org/2001/XMLSchema#string

P921

viral infectious disease

monoclonal antibody

biomedical investigative technique

P932

5034104

http://www.w3.org/2001/XMLSchema#string